Prognoza

Nie mamy danych analityków dla tej spółki.

Wiadomości Przejdź do aktualności

Tempus AI secures $1.1 billion in data contracts, shares rally

Tempus AI said it signed $1.1 billion in sealed data contracts with 70 customers in 2025, including major life-sciences firms such as AstraZeneca, Pfizer, Merck and Abbvie. The company reported revenue retention around 126% and called 2025 a record year for its Data and Applications business. Shares rose as much as 15% intraday and closed up 4.51% at $69.26. Tempus AI plans to finalize and report full 2025 financial results on an earnings call in February 2026. » Więcej na finance.yahoo.com
Tempus AI raises FY25 guidance, cites FDA clearance and Paige acquisition as growth drivers

Tempus AI guided FY25 revenue to $1.25–$1.26 billion (about 81% YoY) and expects roughly $1.55 billion in FY26 revenue, valuing the company at ~9.16x 2026 sales. Recent catalysts include FDA clearance for its xR IVD product and the $81 million acquisition of Paige, which expand addressable markets and AI pathology capabilities. Analysts note strong revenue visibility and execution, while valuation appears supported by forward growth despite a trailing P/E around 41.5 and elevated share performance since April. » Więcej na finance.yahoo.com
Tempus AI reaches all-time high of $98.14

Tempus AI stock climbed to an all-time high of $98.14, bringing market capitalization to about $16.16 billion. Analyst price targets range from $60 to $100; Guggenheim raised its target to $95 and H.C. Wainwright to $98. Tempus recorded revenue growth of 59.84% over the last twelve months and a 1-year performance of +96.54%. The company received FDA 510(k) clearance for the RNA-based diagnostic Tempus xR IVD and expanded its CARE program for breast cancer screening. » Więcej na de.investing.com

Historyczne dywidendy Dywidendy

Wszystkie wskaźniki dywidendowe Wszystkie wskaźniki

W 2023 roku TEMPUS CAPITAL INC. wypłaciła już 0,034 € dywidend. Ostatnia wypłata nastąpiła w sierpień 2023.

Dane finansowe spółki

W ostatnim kwartale TEMPUS CAPITAL INC. osiągnęła przychody w wysokości 73,2 tys. € i zysk netto w wysokości -34,56 tys. €

(EUR)	czerwiec 2026	YoY
Przychody	73,2 tys.	2,72%
Zysk brutto	36,96 tys.	2,92%
Zysk netto	-34,56 tys.	11,85%
EBITDA	2,21 tys.	243,99%

Dane fundamentalne

Wskaźnik	Wartość
Kapitalizacja rynkowa	1,14 mln €
Liczba akcji	30,48 mln
Maksimum/minimum z 52 tygodni	0,0528 € - 0,0249 €
Dywidendy	Nie
Beta	-0,04
C/Z (PE Ratio)	-7,14
PEG (PEG Ratio)	3,59
C/WK (PB Ratio)	1,08
C/S (PS Ratio)	3,71

Profil spółki

Tempus Capital Inc. ist als Immobilienunternehmen in Kanada tätig. Das Immobilienportfolio des Unternehmens umfasst vier Immobilien, darunter eine Gewerbefläche, eine Gewerbeimmobilie und zwei gemischte Gewerbe-/Wohnimmobilien in Ontario. Tempus Capital Inc. wurde im Jahr 2011 gegründet und hat seinen Sitz in Burlington, Kanada.